duraglan tablet prolonged release 4mg base milligrams
jacobsen pharma a/s - doxazosin mesilate - tablet prolonged release - 4mg base milligrams
duraglan 4mg base milligrams tablet prolonged release
jacobsen pharma a/s - doxazosin mesilate - tablet prolonged release - 4mg base milligrams
prenoxad 0.91 mg/ml solution for injection in a pre-filled syringe
aurum pharmaceutical limited - naloxone hydrochloride dihydrate - solution for injection in pre-filled syringe - 0.91 milligram(s)/millilitre - antidotes; naloxone
donepezilhydrochlorid jacobsen 10 mg schmelztabletten
donepezilhydrochlorid jacobsen 5 mg schmelztabletten
adrenalin martindale pharma 0,1 mg/ml injektionsvätska, lösning
salmeterol/flutikason jacobsen 50 mikrogram/500 mikrogram/dos inhalationspulver
silocalm 5mg/5 millilitre oral suspension
jacobsen pharma & medtech advice a/s - clobazam - oral suspension - 5mg/5 millilitre - benzodiazepine derivatives
silocalm 10mg/5 millilitre oral suspension
jacobsen pharma & medtech advice a/s - clobazam - oral suspension - 10mg/5 millilitre - benzodiazepine derivatives
zurampic
grünenthal gmbh - lesinurad - hyperuricemia - antigout preparations - zurampic, in combination with a xanthine oxidase inhibitor, is indicated in adults for the adjunctive treatment of hyperuricaemia in gout patients (with or without tophi) who have not achieved target serum uric acid levels with an adequate dose of a xanthine oxidase inhibitor alone.,